Birth prevalence of disorders detectable through newborn screening by race/ethnicity

Genetics in Medicine

Volumn 14, Issue 11, 2012, Pages 937-945

  Feuchtbaum, Lisa ^a   Carter, Jennifer ^b   Dowray, Sunaina ^b   Currier, Robert J ^a   Lorey, Fred ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b and Children Program   (United States)

Author keywords

birth prevalence; disorders; newborn screening; race and ethnicity

Indexed keywords

HEMOGLOBIN;

ARTICLE; BLOOD SAMPLING; CONGENITAL HYPOTHYROIDISM; CYSTIC FIBROSIS; ENDOCRINE DISEASE; FEMALE; GENETIC DISORDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NEWBORN; NEWBORN SCREENING; PREVALENCE; RACE DIFFERENCE; UNITED STATES;

CALIFORNIA; CONGENITAL HYPOTHYROIDISM; CYSTIC FIBROSIS; ETHNIC GROUPS; GENETIC DISEASES, INBORN; GENETIC TESTING; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; METABOLIC DISEASES; MUTATION; NEONATAL SCREENING; PREVALENCE; SELF REPORT;

EID: 84869060541     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2012.76     Document Type: Article

References (40)

1. American College of Medical Genetics Newbond Screening Expert Group. Newborn screening: toward a uniform screening panel and system. Genet Med 2006;8(suppl 1):1S-252S.
2. Lorey F, Cunningham G, Vichinsky EP, et al. Universal newborn screening for Hb H disease in California. Genet Test 2001;5:93-100. (Pubitemid 32801824)
3. U.S. Department of Health and Human Services. Implementation Guidance on Data Collection Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status 2011. http://aspe.hhs.gov/datacncl/standards/ACA/4302. Accessed 9 March 2012.
4. Cutiongco-de laPaz EM, Abaya EC, Silao LT, Capistrano-Estrada S, David-Padilla C. Mutations of the steroid 21-hydroxylase gene among Filipino patients with congenital adrenal hyperplasia. Acta Med Philipp 2009;43:32-35.
5. Schrijver I. Mutation distribution in expanded screening for cystic fibrosis: making up the balance in a context of ethnic diversity. Clin Chem 2011;57:799-801.
6. Edelmann L, Wasserstein MP, Kornreich R, Sansaricq C, Snyderman SE, Diaz GA. Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population. Am J Hum Genet 2001;69:863-868. (Pubitemid 32868530)
7. Souza AE, Cardoso GL, Takanashi SY, Guerreiro JF. Alpha-thalassemia (3.7 kb deletion) in a population from the Brazilian Amazon region: Santar?, Par State. Genet Mol Res 2009;8:477-481.
8. Matern D, He M, Berry SA, et al. Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. Pediatrics 2003; 112(1 Pt 1):74-78. (Pubitemid 36792932)
9. Hutchesson AC, Bundey S, Preece MA, Hall SK, Green A. A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK. J Med Genet 1998;35:366-370. (Pubitemid 28211630)
10. Lorey FW, Cunningham GC. Birth prevalence of primary congenital hypothyroidism by sex and ethnicity. Hum Biol 1992;64:531-538.
11. Waller DK, Anderson JL, Lorey F, Cunningham GC. Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology 2000;62: 36-41. (Pubitemid 30440442)
12. Michlitsch J, Azimi M, Hoppe C, et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 2009;52:486-490.
13. Hinton CF, Harris KB, Borgfeld L, et al. Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics 2010;125(suppl 2):S37-S47.
14. Bhardwaj U, Zhang YH, Lorey F, McCabe LL, McCabe ER. Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, Southeast Asian, and Chinese beta-thalassemia mutations. Am J Hematol 2005;78: 249-255. (Pubitemid 40471115)
15. McCormick J, Green MW, Mehta G, Culross F, Mehta A. Demographics of the UK cystic fibrosis population: implications for neonatal screening. Eur J Hum Genet 2002;10:583-590. (Pubitemid 35277290)
16. Grant DB, Smith I. Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4. Br Med J (Clin Res Ed) 1988;296:1355-1358.
17. Hoppe CC. Newborn screening for non-sickling hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2009;19-25.
18. Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 2002;19:575-606. (Pubitemid 34556480)
19. The Molecular Genetic Epidemiology of Cystic Fibrosis: Report of a Joint Meeting of WHO/ECFTN/ICF(M)A/ECFS, Genoa, Italy, 19 June 2002. World Health Organization, 2004.
20. California. State and County QuickFacts. 2011 http://quickfacts.census. gov/qfd/states/06000.html. 2011. Accessed 26 August 2011.
21. Pagon RA, Bird TD, Dolan CR, Stephens K, (eds). GeneReviewsTM [Internet]. University of Washington: Seattle, WA, 1993. http://www.ncbi.nim.nih. gov/books/NBK1116/. Accessed 22 June 2011.
22. Feuchtbaum L, Dowray S, Lorey F. The context and approach for the California newborn screening short-and long-term follow-up data system: preliminary findings. Genet Med 2010;12(12 suppl): S242-S250.
23. California Department of Public Health GDB, Newborn Screening Program. Newborn Screening News. 2007: 15. http://www.cdph.ca.gov/programs/nbs/Documents/ NBS-NBSNewsSummer07.pdf. Accessed 25 May 2011.
24. Lorey F. Asian immigration and public health in California: thalassemia in newborns in California. J Pediatr Hematol Oncol 2000;22:564-566.
25. Ren CL, Desai H, Platt M, Dixon M. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Pediatr Pulmonol 2011;46:1079-1084.
26. Wolf B. Biotinidase deficiency. In: Pagon R, Bird T, Dolan C (eds). GeneReviews. University of Washington: Seattle, 2000.
27. Puckett RL, Lorey F, Rinaldo P, et al. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms. Mol Genet Metab 2010;100:136-142.
28. Nair PS, Sobhakumar S, Kailas L. Diagnostic re-evaluation of children with congenital hypothyroidism. Indian Pediatr 2010;47:757-760.
29. Gu YH, Kato T, Harada S, Inomata H, Aoki K. Time trend and geographic distribution of treated patients with congenital hypothyroidism relative to the number of available endocrinologists in Japan. J Pediatr 2010;157:153-157.
30. Lee NC, Tang NL, Chien YH, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab 2010;100:46-50.
31. Niu DM, Chien YH, Chiang CC, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J Inherit Metab Dis 2010;33(suppl 2):S295-S305.
32. van Maldegem BT, Kloosterman SF, Janssen WJ, et al. High prevalence of short-chain acyl-CoA dehydrogenase deficiency in the Netherlands, but no association with epilepsy of unknown origin in childhood. Neuropediatrics 2011;42:13-17.
33. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38(4 suppl):S512-S521.
34. Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of ?thalassemias and hemoglobin E disorders. Expert Rev Hematol 2010;3:103-117.
35. Baumeister L, Marchi K, Pearl M, Williams R, Braveman P. The validity of information on "race" and "Hispanic ethnicity" in California birth certificate data. Health Serv Res 2000;35:869-883.
36. Rebbeck TR, Sankar P. Ethnicity, ancestry, and race in molecular epidemiologic research. Cancer Epidemiol Biomarkers Prev 2005;14(11 Pt 1):2467-2471. (Pubitemid 41752702)
37. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003;348:1170-1175. (Pubitemid 36337330)
38. Kahn J. Genes, race, and population: avoiding a collision of categories. Am J Public Health 2006;96:1965-1970. (Pubitemid 44655921)
39. Boulet SL, Yanni EA, Creary MS, Olney RS. Health status and healthcare use in a national sample of children with sickle cell disease. Am J Prev Med 2010;38(4 suppl):S528-S535.
40. Prabhakar H, Haywood C Jr, Molokie R. Sickle cell disease in the United States: looking back and forward at 100 years of progress in management and survival. Am J Hematol 2010;85: 346-353.